obesity-995x60.png
FEATURED ARTICLES
Patient Input Is A Must — Even Under Time And Money Constraints
Stacie J. Bell, PhD, chief clinical research officer of Lupus Therapeutics, discusses the positive impacts patient advocacy groups can have on patient recruitment, patient retention, protocol design, and more.
-
![A Healing Touch-GettyImages-1764823372]( "Need An Investigator? There's An APP — Advanced Practice Provider — For That")
Need An Investigator? There's An APP — Advanced Practice Provider — For ThatFewer available principal investigators (PIs) is not a new problem for clinical research, but it does necessitate some new and creative solutions. Learn how advanced practice providers (APPs) might help fill the PI gap.
-
![FAIR data practices_GettyImages-1471413999]( "Modern Data Platform Strategies That Accelerate Clinical Development")
Modern Data Platform Strategies That Accelerate Clinical DevelopmentA modern data platform is essential for clinical research because it unifies fragmented data, embeds governance, and enables faster, more reliable decision-making.
-
![Alzheimers disease-GettyImages-648706624]( "Digital Biomarkers Are Reshaping Alzheimer's Patient Experience And Data")
Digital Biomarkers Are Reshaping Alzheimer's Patient Experience And DataCognito CEO Christian Howell shares how EEG and digital biomarkers are reshaping recruitment, patient experience, and the quality of study data in Alzheimer’s research.
SERVICES AND PRODUCTS
With an in-house donor center and database of donors, along with an established network of hospitals and care centers, Precision can source virtually any disease type or sample type biospecimens needed for your project.
As a full-service contract research organization, Southern Star Research has the knowledge, industry relationships and technical expertise to get your early-phase clinical trial up and running safely and efficiently.
Expert ophthalmic teams rescue clinical trials with stabilized studies, nationwide coverage, and eye assessments, helping protect endpoints and regain timeline control quickly.
Antibody-drug conjugates (ADCs) are transforming cancer care by combining precision antibody targeting with potent payloads to improve patient outcomes.
Inflammation is a primary pathogenic process in a wide range of diseases, including rheumatoid arthritis, cardiovascular disease, oncology and neuropsychiatric disorders.
Altasciences’ experienced team specializes in early-phase renal and hepatic impairment studies, delivering tailored clinical pharmacology trials that support your regulatory submissions.